ACHA

(March 3, 2011)

Updated ACHA Recommendations for Institutional Prematriculation Immunizations Now Available

The ACHA Vaccine Preventable Diseases Committee has updated the Recommendations for Institutional Prematriculation Immunizations [pdf]  (RIPI) guidelines document to reflect new vaccine recommendations from the CDC Advisory Committee on Immunization Practices (ACIP).

The RIPI updates include recommendations on:

Meningococcal Meningitis Vaccine Booster: A booster dose is now recommended for those 16 years of age who received the initial dose at age 11-12. If the initial dose was given at 13-15 years, the booster dose should be given at 16-18 years of age. If the initial dose given age at 16 years or older, no booster is needed, except where there is continuing risk.

Tdap Vaccine Booster: A single dose of Tdap booster should be given to adolescents 11-18 and adults 19-64. Tdap can be administered regardless of interval since the last tetanus or diphtheria toxoid-containing vaccine. Adults should receive decennial Td boosters, beginning 10 years after receiving Tdap.

Quadrivalent and Bivalent HPV Vaccine: All female college students 11-26 years old should receive either bivalent or quadrivalent vaccine. Males 9-26 years old can receive quadrivalent HPV vaccine. The quadrivalent vaccine is indicated for prevention of cervical cancers and precancers, anal cancer and anal intraepithelial dysplasia, and genital warts. The bivalent vaccine is indicated for prevention of cervical cancers and precancers.

Influenza Vaccine: Influenza vaccine is now recommended for all individuals over the age of 6 months.

Other immunization information included in the document has been updated as well. The RIPI and other ACHA guidelines and recommendations can be downloaded at www.acha.org/Publications/Guidelines_WhitePapers.cfm.